These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
954 related articles for article (PubMed ID: 34382341)
21. An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment. Liang XJ; Fu RY; Wang HN; Yang J; Yao N; Liu XD; Wang L J Immunol Res; 2021; 2021():5564568. PubMed ID: 34212052 [TBL] [Abstract][Full Text] [Related]
22. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction. Hu X; Wu L; Liu B; Chen K Front Immunol; 2021; 12():651056. PubMed ID: 34122409 [TBL] [Abstract][Full Text] [Related]
23. Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients. Liu G; Ma JY; Hu G; Jin H PLoS One; 2021; 16(7):e0254368. PubMed ID: 34252149 [TBL] [Abstract][Full Text] [Related]
24. Identification of immunotherapy-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognostic signature in gastric carcinoma. Li J; Han T; Yang J; Wang X; Wang Y; Yang R; Yang Q Aging (Albany NY); 2024 Jun; 16(14):11185-11207. PubMed ID: 39074262 [TBL] [Abstract][Full Text] [Related]
25. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma. Shen R; Liu B; Li X; Yu T; Xu K; Ma J BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781 [TBL] [Abstract][Full Text] [Related]
26. Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer. Qiu F; Zhu Y; Shi Y; Ji J; Jin Y Dis Markers; 2021; 2021():4251763. PubMed ID: 34804261 [TBL] [Abstract][Full Text] [Related]
27. A novel immune-related prognostic index for predicting breast cancer overall survival. Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847 [TBL] [Abstract][Full Text] [Related]
28. Identification and verification of the molecular mechanisms and prognostic values of the cadherin gene family in gastric cancer. Luo S; Lin R; Liao X; Li D; Qin Y Sci Rep; 2021 Dec; 11(1):23674. PubMed ID: 34880371 [TBL] [Abstract][Full Text] [Related]
29. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes. Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237 [TBL] [Abstract][Full Text] [Related]
30. Unraveling the unfolded protein response signature: implications for tumor immune microenvironment heterogeneity and clinical prognosis in stomach cancer. Ouyang W; Liu Y; Huang H; Tan Y; Huang Z; Jia X; Yu Y; Yao H Aging (Albany NY); 2024 May; 16(9):7818-7844. PubMed ID: 38700505 [TBL] [Abstract][Full Text] [Related]
31. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
32. Development and validation of a hypoxia- and mitochondrial dysfunction- related prognostic model based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer. Li Y; Cui Y; Wang Z; Wang L; Yu Y; Xiong Y Front Immunol; 2024; 15():1419133. PubMed ID: 39165353 [TBL] [Abstract][Full Text] [Related]
33. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses. Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y Front Immunol; 2021; 12():719628. PubMed ID: 34413861 [TBL] [Abstract][Full Text] [Related]
34. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma. Lei S; Zhang Y Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166 [TBL] [Abstract][Full Text] [Related]
35. Characterizing the Tumor Microenvironment and Its Correlation with cDC1-Related Gene Expression in Gastric Cancer. Han SH; Ju MH J Immunol Res; 2024; 2024():4468145. PubMed ID: 39015755 [TBL] [Abstract][Full Text] [Related]
36. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer. Zhang X; Shi X; Zhao H; Jia X; Yang Y Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055 [TBL] [Abstract][Full Text] [Related]
37. An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer. Yan H; Chen Y; Yang Z; Li Z; Che X; Xiao J; Liu Y; Qu X Front Immunol; 2020; 11():621623. PubMed ID: 33613554 [TBL] [Abstract][Full Text] [Related]
38. Construction and validation of a TTN mutation associated immune prognostic model for evaluating immune microenvironment and outcomes of gastric cancer: An observational study. Chen R; Yao Z; Jiang L Medicine (Baltimore); 2024 Jul; 103(29):e38979. PubMed ID: 39029079 [TBL] [Abstract][Full Text] [Related]
39. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm. Yang Z; Zi Q; Xu K; Wang C; Chi Q Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739 [TBL] [Abstract][Full Text] [Related]
40. Identification of the CD8 + T-cell Related Signature for Predicting the Prognosis of Gastric Cancer Based on Integrated Analysis of Bulk and Single-cell RNA Sequencing Data. Zhu ZG; Wang Z; Wu Q; Miao DL; Jin YQ; Chen L J Immunother; 2024 Sep; 47(7):239-248. PubMed ID: 38809517 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]